UTROGESTAN Side Effects

6432137-X | Aplastic Anaemia, Bone Marrow Failure, Epstein-barr Virus Infection, Ill-defined Disorder, Inflammation, Pancytopenia, Pyrexia
on Oct 28, 2009 Female patient from FRANCE , 65 years of age, was treated with Utrogestan (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, bone marrow failure, epstein-barr virus infection, ill-defined disorder, inflammation, pancytopenia, pyrexia. Utrogestan dosage: Daily Dose: 1 Dosage Form. During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), PIROXICAM (Daily Dose: 200 Milligram(s)) (View Piroxicam Review and Piroxicam Label ), FELDENE (View Feldene Review and Feldene Label ). Patient was hospitalized.

6120497-9 | Hyperaesthesia, Tremor
Patient was taking Utrogestan (View Usage). Patient had the following side effects: hyperaesthesia, tremor on Mar 05, 2009 from FRANCE Additional patient health information: Female patient , 47 years of age, . Utrogestan dosage: . During the same period patient was treated with OESTRODOSE (Daily Dose: 1 Dosage Form) (View Oestrodose Review and Oestrodose Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), URBANYL (View Urbanyl Review and Urbanyl Label ). Patient was hospitalized.

5714466-8 | Abdominal Distension, Abortion Spontaneous, Haemorrhage, Menstrual Disorder, Nausea, Ovarian Cyst, Premature Separation Of Placenta
Adverse event was reported on Apr 15, 2008 by a Female patient taking Utrogestan (View Usage) (Dosage: 1 Tablet, At Night) was diagnosed with haemorrhage, menorrhagia and. Location: BRAZIL , 24 years of age, weighting 155.4 lb, After Utrogestan was administered, patient had the following side effects: abdominal distension, abortion spontaneous, haemorrhage, menstrual disorder, nausea (What is nausea?), ovarian cyst (What is ovarian cyst?), premature separation of placenta. During the same period patient was treated with DACTIL (1 Tablet,tid) (View Dactil Review and Dactil Label ), METHERGINE (125 Mg , Each 8 Hours) (View Methergine Review and Methergine Label ). Patient was hospitalized.

5697430-7 | Abdominal Distension, Abortion Spontaneous, Haemorrhage, Menstrual Disorder, Nausea, Ovarian Cyst, Premature Separation Of Placenta
on Mar 31, 2008 Female patient from BRAZIL , 24 years of age, weighting 155.4 lb, was diagnosed with haemorrhage, menorrhagia and was treated with Utrogestan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abortion spontaneous, haemorrhage, menstrual disorder, nausea (What is nausea?), ovarian cyst (What is ovarian cyst?), premature separation of placenta. Utrogestan dosage: 1 Tablet, At Night. During the same period patient was treated with DACTIL (1 Tablet,tid) (View Dactil Review and Dactil Label ), METHERGINE (125 Mg , Each 8 Hours) (View Methergine Review and Methergine Label ). Patient was hospitalized.


5669607-8 | Abdominal Distension, Abortion Spontaneous, Haemorrhage, Menstrual Disorder, Nausea, Premature Separation Of Placenta
on Mar 12, 2008 Female patient from BRAZIL , 24 years of age, weighting 155.4 lb, was diagnosed with haemorrhage, menorrhagia and was treated with Utrogestan (View Usage). Patient had the following side effects: abdominal distension, abortion spontaneous, haemorrhage, menstrual disorder, nausea (What is nausea?), premature separation of placenta. Utrogestan dosage: 1 Tablet, At Night. During the same period patient was treated with DACTIL (1 Tablet,tid) (View Dactil Review and Dactil Label ), METHERGINE (Unk, Each 8 Hours) (View Methergine Review and Methergine Label ). Patient was hospitalized.

5659577-0 | Bone Marrow Failure, Inflammation, Pancytopenia, Pyrexia, Tonsillitis
Patient was taking Utrogestan (View Usage). After Utrogestan was administered, patient had the following side effects: bone marrow failure, inflammation, pancytopenia, pyrexia, tonsillitis on Feb 29, 2008 from FRANCE Additional patient health information: Female patient , 65 years of age, . Utrogestan dosage: Daily Dose: 100 Milligram(s). During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PIROXICAM (Daily Dose: 2 Dosage Form) (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.

5657389-5 | Abortion Spontaneous, Haemorrhage, Menstrual Disorder, Nausea, Premature Separation Of Placenta
Adverse event was reported on Feb 28, 2008 by a Female patient taking Utrogestan (View Usage) (Dosage: 1 Tablet, At Night) was diagnosed with haemorrhage, menorrhagia and. Location: BRAZIL , 24 years of age, weighting 155.4 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous, haemorrhage, menstrual disorder, nausea (What is nausea?), premature separation of placenta. During the same period patient was treated with DACTIL (1 Tablet,tid) (View Dactil Review and Dactil Label ), METHERGINE (Unk, Each 8 Hours) (View Methergine Review and Methergine Label ). Patient was hospitalized.

5073182-9 | Colitis, Food Poisoning
on Jul 28, 2006 Female patient from FRANCE , 60 years of age, was diagnosed with menopausal symptoms, ill-defined disorder, hypertension, hypercholesterolaemia and was treated with Utrogestan (View Usage). Patient had the following side effects: colitis, food poisoning. Utrogestan dosage: . During the same period patient was treated with OMEPRAZOLE (Daily Dose: 20 Milligram(s)) (View Omeprazole Review and Omeprazole Label ), NEXIUM (View Nexium Review and Nexium Label ), FELDENE (View Feldene Review and Feldene Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), ISOPTINE L (View Isoptine L Review and Isoptine L Label ), PROZAC (View Prozac Review and Prozac Label ), VASTEN (View Vasten Review and Vasten Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

5070520-8 | Colitis, Food Poisoning, Inflammation
on Jul 28, 2006 Female patient from FRANCE , 60 years of age, was diagnosed with menopausal symptoms, ill-defined disorder, hypertension, hypercholesterolaemia and was treated with Utrogestan (View Usage). After Utrogestan was administered, patient had the following side effects: colitis, food poisoning, inflammation. Utrogestan dosage: . During the same period patient was treated with OMEPRAZOLE (Daily Dose: 20 Milligram(s)) (View Omeprazole Review and Omeprazole Label ), NEXIUM (View Nexium Review and Nexium Label ), FELDENE (View Feldene Review and Feldene Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), ISOPTINE L (View Isoptine L Review and Isoptine L Label ), PROZAC (View Prozac Review and Prozac Label ), VASTEN (View Vasten Review and Vasten Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

5021839-8 | Bone Marrow Failure, Inflammation, Pancytopenia, Pyrexia
Patient was taking Utrogestan (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, inflammation, pancytopenia, pyrexia on Apr 05, 2006 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with ill-defined disorder and. Utrogestan dosage: . During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PROXALYOC (Daily Dose: 2 Dosage Form) (View Proxalyoc Review and Proxalyoc Label ). Patient was hospitalized.

5009455-5 | Pancreatitis Acute
Adverse event was reported on May 17, 2006 by a Female patient taking Utrogestan (View Usage) (Dosage: Daily Dose: 100 Milligram(s)) was diagnosed with hot flush and. Location: FRANCE , 52 years of age, Patient had the following side effects: pancreatitis acute. During the same period patient was treated with ESTREVA (Daily Dose: 1.5 Milligram(s)) (View Estreva Review and Estreva Label ). Patient was hospitalized.

5006292-2 | Pain In Extremity
on May 16, 2006 Female patient from FRANCE , 22 years of age, was diagnosed with premature menopause, ill-defined disorder and was treated with Utrogestan (View Usage). After Utrogestan was administered, patient had the following side effects: pain in extremity. Utrogestan dosage: . During the same period patient was treated with ESTROGEL (View Estrogel Review and Estrogel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ORACILLINE (View Oracilline Review and Oracilline Label ), ZECLAR (View Zeclar Review and Zeclar Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ). Patient was hospitalized.

5001789-3 | Abdominal Distension, Abortion Spontaneous, Antepartum Haemorrhage, Anxiety, Dry Mouth, Fatigue, Insomnia, Weight Increased
on May 09, 2006 Female patient from CANADA , 35 years of age, was diagnosed with prophylaxis and was treated with Utrogestan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abortion spontaneous, antepartum haemorrhage, anxiety (What is anxiety?), dry mouth, fatigue, insomnia, weight increased. Utrogestan dosage: Daily Dose: 400 Milligram(s).

4993526-3 | Inflammation, Pancytopenia, Pyrexia, Tonsillitis
Patient was taking Utrogestan (View Usage). Patient had the following side effects: inflammation, pancytopenia, pyrexia, tonsillitis on Apr 05, 2006 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with ill-defined disorder and. Utrogestan dosage: . During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PROXALYOC (Daily Dose: 200 Milligram(s)) (View Proxalyoc Review and Proxalyoc Label ). Patient was hospitalized.

4973870-6 | Bone Marrow Failure, Inflammation, Pancytopenia, Pyrexia
Adverse event was reported on Apr 05, 2006 by a Female patient taking Utrogestan (View Usage) (Dosage: ) was diagnosed with ill-defined disorder and. Location: FRANCE , 65 years of age, After Utrogestan was administered, patient had the following side effects: bone marrow failure, inflammation, pancytopenia, pyrexia. During the same period patient was treated with ALPHAGAN (Daily Dose: 2 Dosage Form) (View Alphagan Review and Alphagan Label ), TANAKAN (Daily Dose: 3 Dosage Form) (View Tanakan Review and Tanakan Label ), FLECAINIDE ACETATE (Daily Dose: 200 Milligram(s)) (View Flecainide Acetate Review and Flecainide Acetate Label ), XALATAN (Daily Dose: 2 Dosage Form) (View Xalatan Review and Xalatan Label ), PROXALYOC (Daily Dose: 200 Milligram(s)) (View Proxalyoc Review and Proxalyoc Label ). Patient was hospitalized.

4918801-X | Ovarian Torsion
on Feb 09, 2006 Female patient from BRAZIL , 35 years of age, was diagnosed with in vitro fertilisation and was treated with Utrogestan (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian torsion. Utrogestan dosage: Daily Dose: 600 Milligram(s). During the same period patient was treated with PROFASI HP (Daily Dose: 10000 International Unit(s)) (View Profasi Hp Review and Profasi Hp Label ), GONAL F (Daily Dose: 225 International Unit(s)) (View Gonal-f Review and Gonal-f Label ), GONAL F (Daily Dose: 150 International Unit(s)) (View Gonal-f Review and Gonal-f Label ), GONAL F (Daily Dose: 75 International Unit(s)) (View Gonal-f Review and Gonal-f Label ), RELISER (Daily Dose: .5 Milligram(s)) (View Reliser Review and Reliser Label ). Patient was hospitalized.

4916467-6 | Abdominal Pain, Caesarean Section, Mass, Ovarian Torsion, Premature Labour, Vomiting
on Feb 09, 2006 Female patient from BRAZIL , 35 years of age, was diagnosed with in vitro fertilisation, ill-defined disorder and was treated with Utrogestan (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), caesarean section, mass, ovarian torsion, premature labour, vomiting. Utrogestan dosage: Daily Dose: 600 Milligram(s). During the same period patient was treated with PROFASI HP (View Profasi Hp Review and Profasi Hp Label ). Patient was hospitalized.

4872671-7 | Hepatic Adenoma
Patient was taking Utrogestan (View Usage). After Utrogestan was administered, patient had the following side effects: hepatic adenoma on Dec 19, 2005 from FRANCE Additional patient health information: Female patient , 43 years of age, was diagnosed with ill-defined disorder, contraception and. Utrogestan dosage: . During the same period patient was treated with PHAEVA (View Phaeva Review and Phaeva Label ). Patient was hospitalized.

4867406-8 | Hepatic Adenoma
Adverse event was reported on Dec 19, 2005 by a Female patient taking Utrogestan (View Usage) (Dosage: ) was diagnosed with ill-defined disorder and. Location: FRANCE , 43 years of age, Patient experienced the following unwanted or unexpected effects: hepatic adenoma. Patient was hospitalized.

4727133-4 | Alanine Aminotransferase Increased, Anxiety, Chest Pain, Colitis Ischaemic, Electrocardiogram Abnormal, Gamma-glutamyltransferase Increased, Intestinal Spasm, Liver Disorder, Rectal Haemorrhage
on Apr 11, 2005 Female patient from FRANCE , 54 years of age, was diagnosed with ill-defined disorder and was treated with Utrogestan (View Usage). Patient had the following side effects: alanine aminotransferase increased, anxiety (What is anxiety?), chest pain (What is chest pain?), colitis ischaemic, electrocardiogram abnormal, gamma-glutamyltransferase increased, intestinal spasm, liver disorder, rectal haemorrhage. Utrogestan dosage: Daily Dose: 1 Dosage Form. During the same period patient was treated with ESTREVA (Daily Dose: 1 Dosage Form) (View Estreva Review and Estreva Label ). Patient was hospitalized and became disabled.